GHO Capital buys ClearView Healthcare Partners in continued North America push

The global strategy consulting firm for the life sciences industry commands a more than $700m valuation, concluding a Houlihan Lokey-conducted sale process.

BySarah Pringle

4 August 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Featured Top Stories

GHO Capital buys ClearView Healthcare Partners in continued North America push

ArchiMed

Ardian

Hellman & Friedman

Houlihan Lokey

RLH Equity Partners

Related articles